Revolution Medicines, Inc. RVMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$453.82M-113% | -$364.89M-87.5% | -$305.21M-95.3% | -$247.79M-86.0% | -$213.42M-84.0% | ||
| $2.35M+38.7% | $2.27M+30.7% | $2.06M+28.9% | $1.76M+9.9% | $1.69M+9.9% | ||
| $87.3M+248% | $33.7M+50.2% | $30.78M+48.2% | $28.83M+45.8% | $25.08M+54.8% | ||
| —— | —— | $0— | $0— | $0-100% | ||
| —— | -$0— | $0— | $0— | $0+100% | ||
| $16.86M+304% | —— | $19.55M+801% | $8.76M+315% | -$8.27M+71.4% | ||
| -$16.74M-1,181% | $54.6M+198% | $45.29M+341% | $10.82M-26.2% | $1.55M+107% | ||
| $10.47M+1,469% | $154K+106% | —— | $17.27M+319% | -$765K-512% | ||
| $5.66M+63.3% | —— | —— | $2.31M+204% | $3.47M+62.7% | ||
| $0-100% | $69K-74.2% | $300K0.0% | $300K0.0% | $267K0.0% | ||
| $2.19M+24.6% | $2.37M+70.8% | $2.01M+108% | $1.78M+100% | $1.76M+83.8% | ||
| -$2.07M-38.1% | —— | —— | -$1.56M-152% | -$1.5M-1,866% | ||
| -$354.17M-82.2% | -$274.24M-98.3% | -$207.31M-59.0% | -$221.76M-73.0% | -$194.44M-21.1% | ||
| $1.54M-52.9% | $1.93M+57.5% | $3.35M-4.9% | $7.45M+211% | $3.27M+3.1% | ||
| $172.62M+1,182% | $74.88M+119% | $24.85M+216% | $34.28M— | -$15.95M+93.6% | ||
| $12.21M+1,270% | -$6.97M-101% | $4.15M— | $1.94M— | $891K— | ||
| —— | $0— | $0— | $0— | $0— | ||
| $238.74M+27,216% | $365.66M-58.2% | $0-100% | $256.58M+3,319% | $874K+7.9% | ||
| $57.19M+127% | —— | -$184.05M-147% | —— | -$209.51M+48.6% | ||
| $3.22M-67.2% | $4.55M-48.4% | $5.72M-40.4% | $7.74M-29.0% | $9.82M-35.6% | ||
| $0-100% | $69K-74.2% | $300K0.0% | $300K0.0% | $267K0.0% | ||
| -$16.74M-1,181% | $54.6M+198% | $45.29M+341% | $10.82M-26.2% | $1.55M+107% | ||
| $10.56M+1,969% | $7.3M+194% | —— | —— | -$565K— | ||
| -$2.07M-38.1% | —— | —— | -$1.56M-152% | -$1.5M-1,866% | ||
| $5.66M+63.3% | —— | —— | $2.31M+204% | $3.47M+62.7% | ||
| $378K+89.0% | —— | —— | —— | $200K— | ||
| $10.47M+263% | $3.38M-33.9% | $5.36M— | $7.36M-11.9% | -$6.43M-1,189% | ||
| $2.19M+24.6% | $2.37M+70.8% | $2.01M+108% | $1.78M+100% | $1.76M+83.8% | ||
| $12.2M— | $11.94M— | $11.43M— | $866K— | $0— | ||
| —— | $0— | $0— | $0— | $0— | ||
| $252K+1,300% | -$191K+32.7% | -$45K— | -$2K— | $18K— | ||
| $226.73M— | $347.92M+683% | —— | —— | $0— | ||
| $12.21M+1,270% | —— | $4.15M+38.1% | $1.94M-55.4% | $891K+10.0% | ||
| $57K+5,600% | —— | $3K— | —— | $1K— | ||
| $786K-71.8% | $454K-52.7% | —— | $122K-86.0% | $2.79M+47.4% | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| -$355.7M-79.9% | -$276.16M-97.9% | -$210.66M-57.3% | -$229.21M-75.5% | -$197.7M-20.8% | ||
| -$355.7M-79.9% | -$276.16M-97.9% | -$210.66M-57.3% | -$229.21M-75.5% | -$197.7M-20.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Revolution Medicines, Inc. generate?
- Revolution Medicines, Inc. (RVMD) generated -$1.1B in operating cash flow over the trailing twelve months.
- What is Revolution Medicines, Inc.'s free cash flow?
- After $14.3M of capital expenditures, Revolution Medicines, Inc.'s free cash flow was -$1.1B over the trailing twelve months, down 78.1% year over year.
- Where does Revolution Medicines, Inc.'s cash flow data come from?
- Every line is extracted from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.